Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer.

O'Dowd C, McRae LA, McMillan DC, Kirk A, Milroy R.

J Thorac Oncol. 2010 Jul;5(7):988-92. doi: 10.1097/JTO.0b013e3181da78f9.

2.

Relationship between tumor size and survival among patients with resection of multiple synchronous lung cancers.

Tanvetyanon T, Robinson L, Sommers KE, Haura E, Kim J, Altiok S, Bepler G.

J Thorac Oncol. 2010 Jul;5(7):1018-24. doi: 10.1097/JTO.0b013e3181dd0fb0.

3.
4.

Clinical outcome of subcentimeter non-small cell lung cancer after surgical resection: single institution experience of 105 patients.

Jiang W, Pang X, Xi J, Chen X, Wang Q, Qian C, Fan H.

J Surg Oncol. 2014 Sep;110(3):233-8. doi: 10.1002/jso.23647. Epub 2014 Jun 2.

PMID:
24888753
5.

Wedge resection verses lobectomy for stage 1 non-small-cell lung cancer.

Warwick R, Mediratta N, Shackcloth M, Page R, McShane J, Shaw M, Poullis M.

Asian Cardiovasc Thorac Ann. 2013 Oct;21(5):566-73. doi: 10.1177/0218492312466861. Epub 2013 Jul 11.

PMID:
24570559
6.

Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.

Koike T, Koike T, Yoshiya K, Tsuchida M, Toyabe S.

J Thorac Cardiovasc Surg. 2013 Aug;146(2):372-8. doi: 10.1016/j.jtcvs.2013.02.057.

7.

Surgical resection of multifocal non-small cell lung cancer is associated with prolonged survival.

Battafarano RJ, Meyers BF, Guthrie TJ, Cooper JD, Patterson GA.

Ann Thorac Surg. 2002 Oct;74(4):988-93; discussion 993-4.

PMID:
12400733
8.
9.

Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).

Ma Q, Liu D, Guo Y, Shi B, Song Z, Tian Y.

Zhongguo Fei Ai Za Zhi. 2010 Apr;13(4):342-8. doi: 10.3779/j.issn.1009-3419.2010.04.14.

10.

Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.

Saji H, Tsuboi M, Yoshida K, Kato Y, Nomura M, Matsubayashi J, Nagao T, Kakihana M, Usuda J, Kajiwara N, Ohira T, Ikeda N.

J Thorac Oncol. 2011 Nov;6(11):1865-71. doi: 10.1097/JTO.0b013e31822a35c3.

11.

[Clinical significance of C-reactive protein in patients with stage I non-small cell lung cancer].

Shen L, Li ZM, Lu S.

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):442-6. Chinese.

PMID:
21875485
12.

Surgical resection and long-term survival for octogenarians who undergo surgery for non-small-cell lung cancer.

Dillman RO, Zusman DR, McClure SE.

Clin Lung Cancer. 2009 Mar;10(2):130-4. doi: 10.3816/CLC.2009.n.017.

PMID:
19362957
13.

Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.

Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Miyaoka E; Japanese Joint Committee of Lung Cancer Registry.

J Thorac Oncol. 2009 Oct;4(10):1247-53. doi: 10.1097/JTO.0b013e3181ae285d.

14.

Surgical treatment of primary lung cancer with synchronous brain metastases.

Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC.

J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53.

15.

Systematic lymph node dissection is necessary for T1a non-small cell lung cancer.

Liu T, Liu H, Li Y.

Asia Pac J Clin Oncol. 2015 Mar;11(1):49-53. doi: 10.1111/ajco.12194. Epub 2014 May 1.

PMID:
24787666
16.

Resection rate and outcome of pulmonary resections for non-small-cell lung cancer: a nationwide study from Iceland.

Thorsteinsson H, Alexandersson A, Oskarsdottir GN, Skuladottir R, Isaksson HJ, Jonsson S, Gudbjartsson T.

J Thorac Oncol. 2012 Jul;7(7):1164-9. doi: 10.1097/JTO.0b013e318252d022.

17.

Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer.

Saitoh Y, Fujisawa T, Shiba M, Yoshida S, Sekine Y, Baba M, Iizasa T, Kubota M.

Lung Cancer. 1999 May;24(2):99-106.

PMID:
10444060
18.

Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.

Zhang PP, Sun JW, Wang XY, Liu XM, Li K.

Eur J Surg Oncol. 2013 Sep;39(9):951-6. doi: 10.1016/j.ejso.2013.06.008. Epub 2013 Jun 28.

PMID:
23810331
19.

Surgical resection is justified in non-small cell lung cancer patients with node negative T4 satellite lesions.

Pennathur A, Lindeman B, Ferson P, Ninan M, Quershi I, Gooding WE, Schuchert M, Christie NA, Landreneau RJ, Luketich JD.

Ann Thorac Surg. 2009 Mar;87(3):893-9. doi: 10.1016/j.athoracsur.2008.11.073.

PMID:
19231415
20.

Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004.

Yoshino I, Yoshida S, Miyaoka E, Asamura H, Nomori H, Fujii Y, Nakanishi Y, Eguchi K, Mori M, Sawabata N, Okumura M, Yokoi K; Japanese Joint Committee of Lung Cancer Registration.

J Thorac Oncol. 2012 May;7(5):850-5. doi: 10.1097/JTO.0b013e31824c945b.

Supplemental Content

Support Center